Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Richard Cotton has a wealth of experience as Chair, SID, Audit Chair, non-executive director (NED), advisory and senior financial roles in life sciences and other industrial sectors.
His extensive experience covers product development, operations and supply chain, and commercial activities in varied international organisations. He has significant experience in the development and successful execution of strategy, corporate finance and M&A, capital markets and governance.
Currently Richard is Audit Chair and Lead Independent Director at Nasdaq-listed AI predictive diagnostics company Spectral AI, and is SID and Audit Committee Chair at AIM-listed topical oxygen wound therapy company AOTI.
Additionally, Richard is Financial Adviser at Novumgen, a privately owned Specialty Pharmaceuticals company, and NED at Sherwood Forest Hospitals NHS Foundation Trust. His prior executive roles include highly successful tenures as CFO at FTSE150 animal health company Dechra Pharmaceuticals plc, and as CFO at medical device and drug formulation business Consort Medical plc.
Fellow of the Chartered Institute of Management Accountants, Mr Cotton holds a BA (Hons) in Business Studies from Kingston University.
No articles found for this topic.
